Skip to content
10-K

Annual Report

OXFORD IMMUNOTEC GLOBAL PLC

0001437749-20-004480

← back to feed
Filed
Mar 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 18, 2020 26.21M sh
Shares Diluted FY 2019 · Dec 31, 2019 26.57M sh
Shares Diluted FY 2019 · Dec 31, 2018 26.4M sh
Stock Repurchased FY 2019 · Dec 31, 2019 $6.99M
Dividends Paid FY 2019 · Dec 31, 2019 $0
Capex FY 2019 · Dec 31, 2019 $1.66M
Capex FY 2019 · Dec 31, 2018 $5.35M
Cash And Equivalents FY 2019 · Dec 31, 2019 $181.27M
Cash And Equivalents FY 2019 · Dec 31, 2018 $192.84M
Stockholders Equity FY 2019 · Dec 31, 2019 $213.69M
Stockholders Equity FY 2019 · Dec 31, 2018 $214.01M
Stockholders Equity FY 2019 · Dec 31, 2017 $87.63M
Current Liabilities FY 2019 · Dec 31, 2019 $13.82M
Current Liabilities FY 2019 · Dec 31, 2018 $18.01M
Total Liabilities FY 2019 · Dec 31, 2019 $21.56M
Total Liabilities FY 2019 · Dec 31, 2018 $18.11M
Current Assets FY 2019 · Dec 31, 2019 $215.88M
Current Assets FY 2019 · Dec 31, 2018 $216.78M
Total Assets FY 2019 · Dec 31, 2019 $235.25M
Total Assets FY 2019 · Dec 31, 2018 $232.12M
Eps Diluted FY 2019 · Dec 31, 2019 −$0.07
Eps Diluted FY 2019 · Dec 31, 2018 $4.58
Eps Basic FY 2019 · Dec 31, 2019 −$0.07
Eps Basic FY 2019 · Dec 31, 2018 $4.65
Sga Expense FY 2019 · Dec 31, 2019 $22.31M
Sga Expense FY 2019 · Dec 31, 2018 $25.95M
Rd Expense FY 2019 · Dec 31, 2019 $8.7M
Rd Expense FY 2019 · Dec 31, 2018 $8.12M
Net Income FY 2019 · Dec 31, 2019 −$1.81M
Net Income FY 2019 · Dec 31, 2018 $120.78M
Operating Income FY 2019 · Dec 31, 2019 −$6.12M
Operating Income FY 2019 · Dec 31, 2018 −$20.72M
Gross Profit FY 2019 · Dec 31, 2019 $54.42M
Gross Profit FY 2019 · Dec 31, 2018 $42.93M